Evidence map›Paper›PMID 40940333›Full record

ArticleNature communications2025

Flexynesis: A deep learning toolkit for bulk multi-omics data integration for precision oncology and beyond.

Bora Uyar, Taras Savchyn, Amirhossein Naghsh Nilchi, Ahmet Sarigun, Ricardo Wurmus, Mohammed Maqsood Shaik, Björn Grüning, Vedran Franke, Altuna Akalin

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Multimodal AI in precision medicine: linking omics, imaging and clinical decisions.American journal of clinical and experimental immunology · 2026
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bora UyarBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany. bora.uyar@mdc-berlin.de.ORCID http://orcid.org/0000-0002-3170-4890
Taras SavchynBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany.
Amirhossein Naghsh NilchiBioinformatics Group, Department of Computer Science, Albert-Ludwigs-University Freiburg, Georges-Köhler-Allee 106, 79110, Freiburg, Germany.ORCID http://orcid.org/0000-0003-1329-3044
Ahmet SarigunBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany.
Ricardo WurmusBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany.ORCID http://orcid.org/0009-0003-0140-4189
Mohammed Maqsood ShaikBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany.
Björn GrüningBioinformatics Group, Department of Computer Science, Albert-Ludwigs-University Freiburg, Georges-Köhler-Allee 106, 79110, Freiburg, Germany.ORCID http://orcid.org/0000-0002-3079-6586
Vedran FrankeBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany.ORCID http://orcid.org/0000-0003-3606-6792
Altuna AkalinBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine, The Berlin Institute for Molecular Systems Biology, Hannoversche Str. 28, 10115, Berlin, Germany. Altuna.Akalin@mdc-berlin.de.ORCID http://orcid.org/0000-0002-0468-0117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate decision making in precision oncology depends on integration of multimodal molecular information, for which various deep learning methods have been developed. However, most deep learning-based bulk multi-omics integration methods lack transparency, modularity, deployability, and are limited to narrow tasks. To address these limitations, we introduce Flexynesis, which streamlines data processing, feature selection, hyperparameter tuning, and marker discovery. Users can choose from deep learning architectures or classical supervised machine learning methods with a standardized input interface for single/multi-task training and evaluation for regression, classification, and survival modeling. We showcase the tool's capability across diverse use-cases in precision oncology. To maximize accessibility, Flexynesis is available on PyPi, Guix, Bioconda, and the Galaxy Server ( https://usegalaxy.eu/ ). This toolset makes deep-learning based bulk multi-omics data integration in clinical/pre-clinical research more accessible to users with or without deep-learning experience. Flexynesis is available at https://github.com/BIMSBbioinfo/flexynesis .

Indexed as

Deep LearningMedical OncologyNeoplasmsPrecision MedicineSoftwareComputational BiologyGenomicsHumansMultiomics

Identifiers

PMID40940333
PMCPMC12432156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.